Anna Mariana

1.2k total citations
16 papers, 677 citations indexed

About

Anna Mariana is a scholar working on Cell Biology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anna Mariana has authored 16 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cell Biology, 9 papers in Molecular Biology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anna Mariana's work include Cellular transport and secretion (10 papers), Retinal Development and Disorders (7 papers) and Acute Lymphoblastic Leukemia research (4 papers). Anna Mariana is often cited by papers focused on Cellular transport and secretion (10 papers), Retinal Development and Disorders (7 papers) and Acute Lymphoblastic Leukemia research (4 papers). Anna Mariana collaborates with scholars based in Australia, United States and New Zealand. Anna Mariana's co-authors include Adam McCluskey, Phillip J. Robinson, Ngoc Chau, Christopher P. Gordon, Luke R. Odell, Megan Chircop, Jennette A. Sakoff, Timothy A. Hill, Andrew B. McGeachie and Mark J. Robertson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Anna Mariana

16 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Mariana Australia 13 368 368 102 83 80 16 677
G. Kornhaber United States 11 507 1.4× 258 0.7× 341 3.3× 44 0.5× 199 2.5× 13 903
F.W. Verheijen Netherlands 19 391 1.1× 212 0.6× 413 4.0× 43 0.5× 77 1.0× 30 878
Shingo Kanemura Japan 16 376 1.0× 343 0.9× 100 1.0× 33 0.4× 16 0.2× 35 782
Carlotta Zamparelli Italy 18 544 1.5× 136 0.4× 48 0.5× 50 0.6× 28 0.3× 30 803
Ashley Thelen United States 6 406 1.1× 235 0.6× 156 1.5× 24 0.3× 17 0.2× 7 778
Tslil Ast Israel 13 855 2.3× 362 1.0× 88 0.9× 47 0.6× 57 0.7× 20 1.1k
Megan C. Yap Canada 9 495 1.3× 293 0.8× 53 0.5× 92 1.1× 30 0.4× 19 636
Qu-Ming Gu United States 7 769 2.1× 500 1.4× 136 1.3× 83 1.0× 34 0.4× 7 905
Aaron J. Morris United States 13 677 1.8× 218 0.6× 102 1.0× 44 0.5× 24 0.3× 16 900
Nancy E. Go Canada 15 591 1.6× 74 0.2× 40 0.4× 20 0.2× 37 0.5× 20 737

Countries citing papers authored by Anna Mariana

Since Specialization
Citations

This map shows the geographic impact of Anna Mariana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mariana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mariana more than expected).

Fields of papers citing papers by Anna Mariana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Mariana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mariana. The network helps show where Anna Mariana may publish in the future.

Co-authorship network of co-authors of Anna Mariana

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Mariana. A scholar is included among the top collaborators of Anna Mariana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Mariana. Anna Mariana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Xiao, Lin, Sandra Cantilena, Anna Mariana, et al.. (2024). FDA-approved disulfiram as a novel treatment for aggressive leukemia. Journal of Molecular Medicine. 102(4). 507–519. 7 indexed citations
2.
Jurek, Russell J., Kimberley A. Beaumont, Anna Mariana, et al.. (2023). Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis. Proceedings of the National Academy of Sciences. 120(47). e2303978120–e2303978120. 2 indexed citations
3.
Mariana, Anna, Ernest Moles, Timothy W. Failes, et al.. (2022). Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia. Frontiers in Oncology. 11. 779859–779859. 3 indexed citations
4.
Mariana, Anna, Andrew J. Gifford, Ursula R. Kees, et al.. (2021). Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin. British Journal of Cancer. 125(1). 55–64. 16 indexed citations
5.
Böhm, Julia, Connor Jones, Kathryn Evans, et al.. (2021). Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia. Leukemia. 35(11). 3101–3112. 21 indexed citations
6.
Abdel‐Hamid, Mohammed K., Kylie A. MacGregor, Luke R. Odell, et al.. (2015). 1,8-Naphthalimide derivatives: new leads against dynamin I GTPase activity. Organic & Biomolecular Chemistry. 13(29). 8016–8028. 19 indexed citations
7.
Robertson, Mark J., Ainslie Whiting, Anna Mariana, et al.. (2012). The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity. ACS Medicinal Chemistry Letters. 3(5). 352–356. 35 indexed citations
8.
Gordon, Christopher P., Mark J. Robertson, Kelly A. Young, et al.. (2012). Development of Second-Generation Indole-Based Dynamin GTPase Inhibitors. Journal of Medicinal Chemistry. 56(1). 46–59. 39 indexed citations
9.
Chircop, Megan, Swetha Perera, Anna Mariana, et al.. (2011). Inhibition of Dynamin by Dynole 34-2 Induces Cell Death following Cytokinesis Failure in Cancer Cells. Molecular Cancer Therapeutics. 10(9). 1553–1562. 47 indexed citations
10.
Harper, Callista B., Sally Martin, Tam Nguyen, et al.. (2011). Dynamin Inhibition Blocks Botulinum Neurotoxin Type A Endocytosis in Neurons and Delays Botulism. Journal of Biological Chemistry. 286(41). 35966–35976. 120 indexed citations
11.
Joshi, Sanket, Swetha Perera, Jayne Gilbert, et al.. (2010). The Dynamin Inhibitors MiTMAB and OcTMAB Induce Cytokinesis Failure and Inhibit Cell Proliferation in Human Cancer Cells. Molecular Cancer Therapeutics. 9(7). 1995–2006. 63 indexed citations
12.
Hill, Timothy A., Anna Mariana, Christopher P. Gordon, et al.. (2010). Iminochromene Inhibitors of Dynamins I and II GTPase Activity and Endocytosis. Journal of Medicinal Chemistry. 53(10). 4094–4102. 53 indexed citations
13.
Odell, Luke R., Christopher P. Gordon, Mark J. Robertson, et al.. (2010). The Pthaladyns: GTP Competitive Inhibitors of Dynamin I and II GTPase Derived from Virtual Screening. Journal of Medicinal Chemistry. 53(14). 5267–5280. 43 indexed citations
14.
Odell, Luke R., Ngoc Chau, Anna Mariana, et al.. (2009). Azido and Diazarinyl Analogues of Bis‐Tyrphostin as Asymmetrical Inhibitors of Dynamin GTPase. ChemMedChem. 4(7). 1182–1188. 33 indexed citations
15.
Hill, Timothy A., Christopher P. Gordon, Andrew B. McGeachie, et al.. (2009). Inhibition of Dynamin Mediated Endocytosis by the Dynoles—Synthesis and Functional Activity of a Family of Indoles. Journal of Medicinal Chemistry. 52(12). 3762–3773. 138 indexed citations
16.
Mariana, Anna, Barry Lai, Stefan Vogt, et al.. (2008). Microprobe XRF Mapping and XAS Investigations of the Intracellular Metabolism of Arsenic for Understanding Arsenic-Induced Toxicity. Chemical Research in Toxicology. 21(9). 1760–1769. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Kornhaber Breakdown of academic impact, for papers by F.W. Verheijen Breakdown of academic impact, for papers by Shingo Kanemura Breakdown of academic impact, for papers by Carlotta Zamparelli Breakdown of academic impact, for papers by Ashley Thelen Breakdown of academic impact, for papers by Tslil Ast Breakdown of academic impact, for papers by Megan C. Yap Breakdown of academic impact, for papers by Qu-Ming Gu Breakdown of academic impact, for papers by Aaron J. Morris Breakdown of academic impact, for papers by Nancy E. Go
Rankless by CCL
2026